Response by Pennlert et al to Letter Regarding Article, “Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
We thank Nielsen and Johnsen for their interest in our article1 and valuable comments on how to clinically interpret our results. Current European Society of Cardiology (ESC) guidelines2 regarding anticoagulation in patients with atrial fibrillation after intracranial hemorrhages are based on observational, nonrandomized data, as is our study. Our contribution has been the specific focus on the optimal timing of anticoagulant treatment in patients with atrial fibrillation who have survived nontraumatic intracerebral hemorrhages (International Classification of Diseases [ICD]-10 diagnosis: I61) when clinicians, in the absence of evidence from randomized trials, have chosen to treat. …